SMTL ID : 6q6f.1

Crystal structure of IDH1 R132H in complex with HMS101

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.30 Å

Oligo State

homo-dimer

Ligands

2 x HJQ: (2~{R})-2-[2-[(3~{R})-3-(4-fluorophenyl)pyrrolidin-1-yl]ethyl]-1,4-dimethyl-piperazine(Non-covalent)

HJQ.1: 11 residues within 4Å: Chain A: S.287, L.288, H.309, G.310, T.311, V.312, T.313, R.314, T.327, N.328, D.375 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:V.312, A:N.328 Hydrogen bonds: A:R.314 pi-Cation interactions: A:H.315 Halogen bonds: A:N.328 HJQ.2: 10 residues within 4Å: Chain B: G.289, H.309, G.310, T.311, V.312, T.313, R.314, H.315, N.328, D.375 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:G.310 Halogen bonds: B:N.328

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chaturvedi, A. et al., In vivo efficacy of mutant IDH1 inhibitor HMS-101 and structural resolution of distinct binding site. Leukemia (2020)

Release Date

2019-10-16

Peptides

Isocitrate dehydrogenase [NADP] cytoplasmic: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Isocitrate dehydrogenase [NADP] cytoplasmic

Related Entries With Identical Sequence